nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—MAP3K7—uterine cervix—vulva cancer	0.00272	0.00272	CbGeAlD
Sunitinib—STK17B—lymph node—vulva cancer	0.00271	0.00271	CbGeAlD
Sunitinib—CSNK1A1—mammalian vulva—vulva cancer	0.00271	0.00271	CbGeAlD
Sunitinib—CLK1—mammalian vulva—vulva cancer	0.00269	0.00269	CbGeAlD
Sunitinib—TBK1—uterine cervix—vulva cancer	0.00268	0.00268	CbGeAlD
Sunitinib—TYK2—uterine cervix—vulva cancer	0.00267	0.00267	CbGeAlD
Sunitinib—STK24—vagina—vulva cancer	0.00264	0.00264	CbGeAlD
Sunitinib—CSNK1E—urethra—vulva cancer	0.00264	0.00264	CbGeAlD
Sunitinib—FGFR1—urethra—vulva cancer	0.00264	0.00264	CbGeAlD
Sunitinib—IRAK1—uterine cervix—vulva cancer	0.00263	0.00263	CbGeAlD
Sunitinib—LRRK2—mammalian vulva—vulva cancer	0.00262	0.00262	CbGeAlD
Sunitinib—DAPK2—vagina—vulva cancer	0.00261	0.00261	CbGeAlD
Sunitinib—RPS6KB1—epithelium—vulva cancer	0.0026	0.0026	CbGeAlD
Sunitinib—IRAK4—urethra—vulva cancer	0.00259	0.00259	CbGeAlD
Sunitinib—RET—epithelium—vulva cancer	0.00259	0.00259	CbGeAlD
Sunitinib—RPS6KB1—uterine cervix—vulva cancer	0.00258	0.00258	CbGeAlD
Sunitinib—STK16—vagina—vulva cancer	0.00256	0.00256	CbGeAlD
Sunitinib—AXL—uterine cervix—vulva cancer	0.00256	0.00256	CbGeAlD
Sunitinib—HIPK3—vagina—vulva cancer	0.00255	0.00255	CbGeAlD
Sunitinib—ULK3—urethra—vulva cancer	0.00254	0.00254	CbGeAlD
Sunitinib—MAP2K2—urethra—vulva cancer	0.00254	0.00254	CbGeAlD
Sunitinib—RIOK2—vagina—vulva cancer	0.00252	0.00252	CbGeAlD
Sunitinib—TNK1—vagina—vulva cancer	0.00252	0.00252	CbGeAlD
Sunitinib—FGFR1—mammalian vulva—vulva cancer	0.00251	0.00251	CbGeAlD
Sunitinib—CSNK1E—mammalian vulva—vulva cancer	0.00251	0.00251	CbGeAlD
Sunitinib—MAP4K1—vagina—vulva cancer	0.0025	0.0025	CbGeAlD
Sunitinib—STK17A—lymph node—vulva cancer	0.0025	0.0025	CbGeAlD
Sunitinib—MAP3K7—urethra—vulva cancer	0.0025	0.0025	CbGeAlD
Sunitinib—IRAK4—mammalian vulva—vulva cancer	0.00247	0.00247	CbGeAlD
Sunitinib—TBK1—urethra—vulva cancer	0.00247	0.00247	CbGeAlD
Sunitinib—SLK—uterine cervix—vulva cancer	0.00246	0.00246	CbGeAlD
Sunitinib—CDK14—lymph node—vulva cancer	0.00246	0.00246	CbGeAlD
Sunitinib—FGFR2—epithelium—vulva cancer	0.00246	0.00246	CbGeAlD
Sunitinib—DAPK3—vagina—vulva cancer	0.00245	0.00245	CbGeAlD
Sunitinib—TYK2—urethra—vulva cancer	0.00245	0.00245	CbGeAlD
Sunitinib—JAK2—epithelium—vulva cancer	0.00245	0.00245	CbGeAlD
Sunitinib—FGFR2—uterine cervix—vulva cancer	0.00244	0.00244	CbGeAlD
Sunitinib—CLK2—vagina—vulva cancer	0.00243	0.00243	CbGeAlD
Sunitinib—JAK2—uterine cervix—vulva cancer	0.00243	0.00243	CbGeAlD
Sunitinib—CDK16—lymph node—vulva cancer	0.00243	0.00243	CbGeAlD
Sunitinib—LATS2—lymph node—vulva cancer	0.00243	0.00243	CbGeAlD
Sunitinib—PAK3—lymph node—vulva cancer	0.00243	0.00243	CbGeAlD
Sunitinib—MAP4K2—vagina—vulva cancer	0.00242	0.00242	CbGeAlD
Sunitinib—MAP2K2—mammalian vulva—vulva cancer	0.00242	0.00242	CbGeAlD
Sunitinib—ULK3—mammalian vulva—vulva cancer	0.00242	0.00242	CbGeAlD
Sunitinib—RPS6KA5—lymph node—vulva cancer	0.00239	0.00239	CbGeAlD
Sunitinib—FYN—uterine cervix—vulva cancer	0.00239	0.00239	CbGeAlD
Sunitinib—STK3—vagina—vulva cancer	0.00238	0.00238	CbGeAlD
Sunitinib—MAP3K7—mammalian vulva—vulva cancer	0.00238	0.00238	CbGeAlD
Sunitinib—RPS6KB1—urethra—vulva cancer	0.00237	0.00237	CbGeAlD
Sunitinib—FGR—urethra—vulva cancer	0.00236	0.00236	CbGeAlD
Sunitinib—AXL—urethra—vulva cancer	0.00235	0.00235	CbGeAlD
Sunitinib—TBK1—mammalian vulva—vulva cancer	0.00235	0.00235	CbGeAlD
Sunitinib—MAP4K5—uterine cervix—vulva cancer	0.00234	0.00234	CbGeAlD
Sunitinib—MAP3K3—uterine cervix—vulva cancer	0.00234	0.00234	CbGeAlD
Sunitinib—TYK2—mammalian vulva—vulva cancer	0.00233	0.00233	CbGeAlD
Sunitinib—CLK4—lymph node—vulva cancer	0.0023	0.0023	CbGeAlD
Sunitinib—IRAK1—mammalian vulva—vulva cancer	0.0023	0.0023	CbGeAlD
Sunitinib—FLT1—epithelium—vulva cancer	0.00228	0.00228	CbGeAlD
Sunitinib—SBK1—lymph node—vulva cancer	0.00228	0.00228	CbGeAlD
Sunitinib—ITK—lymph node—vulva cancer	0.00228	0.00228	CbGeAlD
Sunitinib—SLK—urethra—vulva cancer	0.00226	0.00226	CbGeAlD
Sunitinib—FLT1—uterine cervix—vulva cancer	0.00226	0.00226	CbGeAlD
Sunitinib—RPS6KB1—mammalian vulva—vulva cancer	0.00226	0.00226	CbGeAlD
Sunitinib—BLK—lymph node—vulva cancer	0.00225	0.00225	CbGeAlD
Sunitinib—FGR—mammalian vulva—vulva cancer	0.00225	0.00225	CbGeAlD
Sunitinib—MERTK—vagina—vulva cancer	0.00224	0.00224	CbGeAlD
Sunitinib—AXL—mammalian vulva—vulva cancer	0.00224	0.00224	CbGeAlD
Sunitinib—EPHB6—uterine cervix—vulva cancer	0.00223	0.00223	CbGeAlD
Sunitinib—JAK2—urethra—vulva cancer	0.00223	0.00223	CbGeAlD
Sunitinib—PHKG1—lymph node—vulva cancer	0.00222	0.00222	CbGeAlD
Sunitinib—DAPK1—lymph node—vulva cancer	0.00222	0.00222	CbGeAlD
Sunitinib—MAP4K4—vagina—vulva cancer	0.0022	0.0022	CbGeAlD
Sunitinib—FYN—urethra—vulva cancer	0.0022	0.0022	CbGeAlD
Sunitinib—NUAK2—vagina—vulva cancer	0.00218	0.00218	CbGeAlD
Sunitinib—MAP3K12—vagina—vulva cancer	0.00217	0.00217	CbGeAlD
Sunitinib—YES1—uterine cervix—vulva cancer	0.00216	0.00216	CbGeAlD
Sunitinib—STK11—lymph node—vulva cancer	0.00215	0.00215	CbGeAlD
Sunitinib—BRD4—lymph node—vulva cancer	0.00215	0.00215	CbGeAlD
Sunitinib—SLK—mammalian vulva—vulva cancer	0.00215	0.00215	CbGeAlD
Sunitinib—MAP4K5—urethra—vulva cancer	0.00215	0.00215	CbGeAlD
Sunitinib—MAP3K3—urethra—vulva cancer	0.00215	0.00215	CbGeAlD
Sunitinib—STK10—uterine cervix—vulva cancer	0.00214	0.00214	CbGeAlD
Sunitinib—RPS6KA3—vagina—vulva cancer	0.00214	0.00214	CbGeAlD
Sunitinib—RPS6KA1—lymph node—vulva cancer	0.00213	0.00213	CbGeAlD
Sunitinib—RIOK1—lymph node—vulva cancer	0.00213	0.00213	CbGeAlD
Sunitinib—TAOK3—uterine cervix—vulva cancer	0.00213	0.00213	CbGeAlD
Sunitinib—JAK2—mammalian vulva—vulva cancer	0.00212	0.00212	CbGeAlD
Sunitinib—CSNK1A1—vagina—vulva cancer	0.0021	0.0021	CbGeAlD
Sunitinib—FYN—mammalian vulva—vulva cancer	0.00209	0.00209	CbGeAlD
Sunitinib—TNIK—lymph node—vulva cancer	0.00209	0.00209	CbGeAlD
Sunitinib—MARK2—lymph node—vulva cancer	0.00209	0.00209	CbGeAlD
Sunitinib—CLK1—vagina—vulva cancer	0.00208	0.00208	CbGeAlD
Sunitinib—FLT1—urethra—vulva cancer	0.00208	0.00208	CbGeAlD
Sunitinib—SGK3—lymph node—vulva cancer	0.00207	0.00207	CbGeAlD
Sunitinib—EPHB6—urethra—vulva cancer	0.00205	0.00205	CbGeAlD
Sunitinib—ICK—lymph node—vulva cancer	0.00205	0.00205	CbGeAlD
Sunitinib—MAP3K3—mammalian vulva—vulva cancer	0.00205	0.00205	CbGeAlD
Sunitinib—MAP4K5—mammalian vulva—vulva cancer	0.00205	0.00205	CbGeAlD
Sunitinib—CAMK2G—vagina—vulva cancer	0.00205	0.00205	CbGeAlD
Sunitinib—BMP2K—vagina—vulva cancer	0.00205	0.00205	CbGeAlD
Sunitinib—LRRK2—vagina—vulva cancer	0.00203	0.00203	CbGeAlD
Sunitinib—YES1—urethra—vulva cancer	0.00198	0.00198	CbGeAlD
Sunitinib—CHEK2—lymph node—vulva cancer	0.00198	0.00198	CbGeAlD
Sunitinib—NUAK1—lymph node—vulva cancer	0.00198	0.00198	CbGeAlD
Sunitinib—FLT1—mammalian vulva—vulva cancer	0.00198	0.00198	CbGeAlD
Sunitinib—PTK2B—vagina—vulva cancer	0.00198	0.00198	CbGeAlD
Sunitinib—INSR—lymph node—vulva cancer	0.00197	0.00197	CbGeAlD
Sunitinib—OXSR1—lymph node—vulva cancer	0.00197	0.00197	CbGeAlD
Sunitinib—SNRK—lymph node—vulva cancer	0.00197	0.00197	CbGeAlD
Sunitinib—TAOK3—urethra—vulva cancer	0.00196	0.00196	CbGeAlD
Sunitinib—EPHB6—mammalian vulva—vulva cancer	0.00196	0.00196	CbGeAlD
Sunitinib—CSNK1E—vagina—vulva cancer	0.00194	0.00194	CbGeAlD
Sunitinib—FGFR1—vagina—vulva cancer	0.00194	0.00194	CbGeAlD
Sunitinib—STK38—lymph node—vulva cancer	0.00194	0.00194	CbGeAlD
Sunitinib—RPS6KA2—lymph node—vulva cancer	0.00194	0.00194	CbGeAlD
Sunitinib—KDR—epithelium—vulva cancer	0.00193	0.00193	CbGeAlD
Sunitinib—AURKC—lymph node—vulva cancer	0.00192	0.00192	CbGeAlD
Sunitinib—IRAK4—vagina—vulva cancer	0.00191	0.00191	CbGeAlD
Sunitinib—KDR—uterine cervix—vulva cancer	0.00191	0.00191	CbGeAlD
Sunitinib—MAP2K5—uterine cervix—vulva cancer	0.00191	0.00191	CbGeAlD
Sunitinib—CSNK1G2—lymph node—vulva cancer	0.00191	0.00191	CbGeAlD
Sunitinib—PKN1—lymph node—vulva cancer	0.00191	0.00191	CbGeAlD
Sunitinib—YES1—mammalian vulva—vulva cancer	0.00189	0.00189	CbGeAlD
Sunitinib—PRPF4—lymph node—vulva cancer	0.00188	0.00188	CbGeAlD
Sunitinib—STK10—mammalian vulva—vulva cancer	0.00187	0.00187	CbGeAlD
Sunitinib—ULK3—vagina—vulva cancer	0.00187	0.00187	CbGeAlD
Sunitinib—TAOK3—mammalian vulva—vulva cancer	0.00187	0.00187	CbGeAlD
Sunitinib—CSF1R—uterine cervix—vulva cancer	0.00187	0.00187	CbGeAlD
Sunitinib—PRPF4B—lymph node—vulva cancer	0.00185	0.00185	CbGeAlD
Sunitinib—MAP3K7—vagina—vulva cancer	0.00184	0.00184	CbGeAlD
Sunitinib—STK39—lymph node—vulva cancer	0.00183	0.00183	CbGeAlD
Sunitinib—TBK1—vagina—vulva cancer	0.00182	0.00182	CbGeAlD
Sunitinib—TYK2—vagina—vulva cancer	0.00181	0.00181	CbGeAlD
Sunitinib—CSNK2A1—lymph node—vulva cancer	0.0018	0.0018	CbGeAlD
Sunitinib—MYLK—lymph node—vulva cancer	0.00178	0.00178	CbGeAlD
Sunitinib—PLK4—lymph node—vulva cancer	0.00176	0.00176	CbGeAlD
Sunitinib—MAP2K5—urethra—vulva cancer	0.00176	0.00176	CbGeAlD
Sunitinib—KDR—urethra—vulva cancer	0.00176	0.00176	CbGeAlD
Sunitinib—RPS6KB1—vagina—vulva cancer	0.00175	0.00175	CbGeAlD
Sunitinib—STK4—lymph node—vulva cancer	0.00175	0.00175	CbGeAlD
Sunitinib—FGR—vagina—vulva cancer	0.00174	0.00174	CbGeAlD
Sunitinib—AXL—vagina—vulva cancer	0.00173	0.00173	CbGeAlD
Sunitinib—PHKG2—lymph node—vulva cancer	0.00172	0.00172	CbGeAlD
Sunitinib—CSF1R—urethra—vulva cancer	0.00171	0.00171	CbGeAlD
Sunitinib—KIT—epithelium—vulva cancer	0.00171	0.00171	CbGeAlD
Sunitinib—STK24—lymph node—vulva cancer	0.00171	0.00171	CbGeAlD
Sunitinib—KIT—uterine cervix—vulva cancer	0.00169	0.00169	CbGeAlD
Sunitinib—DAPK2—lymph node—vulva cancer	0.00169	0.00169	CbGeAlD
Sunitinib—KDR—mammalian vulva—vulva cancer	0.00167	0.00167	CbGeAlD
Sunitinib—MAP2K5—mammalian vulva—vulva cancer	0.00167	0.00167	CbGeAlD
Sunitinib—PDGFRB—epithelium—vulva cancer	0.00167	0.00167	CbGeAlD
Sunitinib—SLK—vagina—vulva cancer	0.00167	0.00167	CbGeAlD
Sunitinib—STK16—lymph node—vulva cancer	0.00166	0.00166	CbGeAlD
Sunitinib—PDGFRB—uterine cervix—vulva cancer	0.00165	0.00165	CbGeAlD
Sunitinib—HIPK2—lymph node—vulva cancer	0.00165	0.00165	CbGeAlD
Sunitinib—HIPK3—lymph node—vulva cancer	0.00165	0.00165	CbGeAlD
Sunitinib—ALK—lymph node—vulva cancer	0.00165	0.00165	CbGeAlD
Sunitinib—JAK2—vagina—vulva cancer	0.00164	0.00164	CbGeAlD
Sunitinib—TNK1—lymph node—vulva cancer	0.00163	0.00163	CbGeAlD
Sunitinib—RIOK2—lymph node—vulva cancer	0.00163	0.00163	CbGeAlD
Sunitinib—CSF1R—mammalian vulva—vulva cancer	0.00163	0.00163	CbGeAlD
Sunitinib—FYN—vagina—vulva cancer	0.00162	0.00162	CbGeAlD
Sunitinib—MAP4K1—lymph node—vulva cancer	0.00162	0.00162	CbGeAlD
Sunitinib—DAPK3—lymph node—vulva cancer	0.00159	0.00159	CbGeAlD
Sunitinib—MAP3K3—vagina—vulva cancer	0.00158	0.00158	CbGeAlD
Sunitinib—MAP4K5—vagina—vulva cancer	0.00158	0.00158	CbGeAlD
Sunitinib—CLK2—lymph node—vulva cancer	0.00157	0.00157	CbGeAlD
Sunitinib—MAP4K2—lymph node—vulva cancer	0.00156	0.00156	CbGeAlD
Sunitinib—KIT—urethra—vulva cancer	0.00156	0.00156	CbGeAlD
Sunitinib—STK3—lymph node—vulva cancer	0.00154	0.00154	CbGeAlD
Sunitinib—FLT1—vagina—vulva cancer	0.00153	0.00153	CbGeAlD
Sunitinib—PDGFRB—urethra—vulva cancer	0.00152	0.00152	CbGeAlD
Sunitinib—EPHB6—vagina—vulva cancer	0.00151	0.00151	CbGeAlD
Sunitinib—DYRK1A—lymph node—vulva cancer	0.00148	0.00148	CbGeAlD
Sunitinib—KIT—mammalian vulva—vulva cancer	0.00148	0.00148	CbGeAlD
Sunitinib—YES1—vagina—vulva cancer	0.00146	0.00146	CbGeAlD
Sunitinib—STK10—vagina—vulva cancer	0.00145	0.00145	CbGeAlD
Sunitinib—MERTK—lymph node—vulva cancer	0.00145	0.00145	CbGeAlD
Sunitinib—PDGFRB—mammalian vulva—vulva cancer	0.00145	0.00145	CbGeAlD
Sunitinib—TAOK3—vagina—vulva cancer	0.00144	0.00144	CbGeAlD
Sunitinib—PDGFRA—vagina—vulva cancer	0.00144	0.00144	CbGeAlD
Sunitinib—MAP4K4—lymph node—vulva cancer	0.00142	0.00142	CbGeAlD
Sunitinib—NUAK2—lymph node—vulva cancer	0.00141	0.00141	CbGeAlD
Sunitinib—FLT3—lymph node—vulva cancer	0.0014	0.0014	CbGeAlD
Sunitinib—MAP3K12—lymph node—vulva cancer	0.0014	0.0014	CbGeAlD
Sunitinib—RPS6KA3—lymph node—vulva cancer	0.00138	0.00138	CbGeAlD
Sunitinib—MAP2K1—lymph node—vulva cancer	0.00137	0.00137	CbGeAlD
Sunitinib—CSNK1A1—lymph node—vulva cancer	0.00136	0.00136	CbGeAlD
Sunitinib—CLK1—lymph node—vulva cancer	0.00135	0.00135	CbGeAlD
Sunitinib—CAMK2G—lymph node—vulva cancer	0.00132	0.00132	CbGeAlD
Sunitinib—BMP2K—lymph node—vulva cancer	0.00132	0.00132	CbGeAlD
Sunitinib—LRRK2—lymph node—vulva cancer	0.00131	0.00131	CbGeAlD
Sunitinib—KDR—vagina—vulva cancer	0.00129	0.00129	CbGeAlD
Sunitinib—MAP2K5—vagina—vulva cancer	0.00129	0.00129	CbGeAlD
Sunitinib—PRKAA1—lymph node—vulva cancer	0.00129	0.00129	CbGeAlD
Sunitinib—PTK2B—lymph node—vulva cancer	0.00128	0.00128	CbGeAlD
Sunitinib—FLT4—lymph node—vulva cancer	0.00127	0.00127	CbGeAlD
Sunitinib—CSF1R—vagina—vulva cancer	0.00126	0.00126	CbGeAlD
Sunitinib—CSNK1E—lymph node—vulva cancer	0.00126	0.00126	CbGeAlD
Sunitinib—FGFR1—lymph node—vulva cancer	0.00126	0.00126	CbGeAlD
Sunitinib—IRAK4—lymph node—vulva cancer	0.00124	0.00124	CbGeAlD
Sunitinib—MAP2K2—lymph node—vulva cancer	0.00121	0.00121	CbGeAlD
Sunitinib—ULK3—lymph node—vulva cancer	0.00121	0.00121	CbGeAlD
Sunitinib—MAP3K2—lymph node—vulva cancer	0.0012	0.0012	CbGeAlD
Sunitinib—MAP3K7—lymph node—vulva cancer	0.00119	0.00119	CbGeAlD
Sunitinib—TBK1—lymph node—vulva cancer	0.00118	0.00118	CbGeAlD
Sunitinib—TYK2—lymph node—vulva cancer	0.00117	0.00117	CbGeAlD
Sunitinib—IRAK1—lymph node—vulva cancer	0.00115	0.00115	CbGeAlD
Sunitinib—KIT—vagina—vulva cancer	0.00115	0.00115	CbGeAlD
Sunitinib—RPS6KB1—lymph node—vulva cancer	0.00113	0.00113	CbGeAlD
Sunitinib—FGR—lymph node—vulva cancer	0.00113	0.00113	CbGeAlD
Sunitinib—RET—lymph node—vulva cancer	0.00113	0.00113	CbGeAlD
Sunitinib—PDGFRB—vagina—vulva cancer	0.00112	0.00112	CbGeAlD
Sunitinib—AXL—lymph node—vulva cancer	0.00112	0.00112	CbGeAlD
Sunitinib—SLK—lymph node—vulva cancer	0.00108	0.00108	CbGeAlD
Sunitinib—JAK2—lymph node—vulva cancer	0.00106	0.00106	CbGeAlD
Sunitinib—FYN—lymph node—vulva cancer	0.00105	0.00105	CbGeAlD
Sunitinib—KCNH2—uterine cervix—vulva cancer	0.00105	0.00105	CbGeAlD
Sunitinib—MAP4K5—lymph node—vulva cancer	0.00102	0.00102	CbGeAlD
Sunitinib—MAP3K3—lymph node—vulva cancer	0.00102	0.00102	CbGeAlD
Sunitinib—FLT1—lymph node—vulva cancer	0.000991	0.000991	CbGeAlD
Sunitinib—EPHB6—lymph node—vulva cancer	0.000979	0.000979	CbGeAlD
Sunitinib—KCNH2—urethra—vulva cancer	0.00096	0.00096	CbGeAlD
Sunitinib—YES1—lymph node—vulva cancer	0.000946	0.000946	CbGeAlD
Sunitinib—STK10—lymph node—vulva cancer	0.000938	0.000938	CbGeAlD
Sunitinib—TAOK3—lymph node—vulva cancer	0.000934	0.000934	CbGeAlD
Sunitinib—ABCG2—uterine cervix—vulva cancer	0.00093	0.00093	CbGeAlD
Sunitinib—PDGFRA—lymph node—vulva cancer	0.000928	0.000928	CbGeAlD
Sunitinib—CYP3A5—uterine cervix—vulva cancer	0.000863	0.000863	CbGeAlD
Sunitinib—ABCG2—urethra—vulva cancer	0.000854	0.000854	CbGeAlD
Sunitinib—KDR—lymph node—vulva cancer	0.000838	0.000838	CbGeAlD
Sunitinib—MAP2K5—lymph node—vulva cancer	0.000838	0.000838	CbGeAlD
Sunitinib—CSF1R—lymph node—vulva cancer	0.000817	0.000817	CbGeAlD
Sunitinib—ABCG2—mammalian vulva—vulva cancer	0.000813	0.000813	CbGeAlD
Sunitinib—KIT—lymph node—vulva cancer	0.000742	0.000742	CbGeAlD
Sunitinib—PDGFRB—lymph node—vulva cancer	0.000725	0.000725	CbGeAlD
Sunitinib—KCNH2—vagina—vulva cancer	0.000708	0.000708	CbGeAlD
Sunitinib—ABCG2—vagina—vulva cancer	0.00063	0.00063	CbGeAlD
Sunitinib—CYP3A5—vagina—vulva cancer	0.000585	0.000585	CbGeAlD
Sunitinib—ABCC4—lymph node—vulva cancer	0.000577	0.000577	CbGeAlD
Sunitinib—ABCC2—lymph node—vulva cancer	0.000559	0.000559	CbGeAlD
Sunitinib—ABCB1—epithelium—vulva cancer	0.000462	0.000462	CbGeAlD
Sunitinib—ABCB1—uterine cervix—vulva cancer	0.000458	0.000458	CbGeAlD
Sunitinib—KCNH2—lymph node—vulva cancer	0.000458	0.000458	CbGeAlD
Sunitinib—ABCB1—urethra—vulva cancer	0.000421	0.000421	CbGeAlD
Sunitinib—ABCG2—lymph node—vulva cancer	0.000407	0.000407	CbGeAlD
Sunitinib—ABCB1—mammalian vulva—vulva cancer	0.000401	0.000401	CbGeAlD
Sunitinib—ABCB1—vagina—vulva cancer	0.000311	0.000311	CbGeAlD
Sunitinib—ABCB1—lymph node—vulva cancer	0.000201	0.000201	CbGeAlD
